Pieris Pharmaceuticals
Why Robinhood?
You can watch PIRS and buy or sell other stocks, ETFs, and their options commission-free!About PIRS
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas.
PIRS Key Statistics
Stock Snapshot
With a market cap of 120.71M, Pieris Pharmaceuticals(PIRS) trades at $9.75. The stock has a price-to-earnings ratio of -1.08.
On 2026-04-24, Pieris Pharmaceuticals(PIRS) stock opened at —, reached a high of —, and a low of —.
Pieris Pharmaceuticals(PIRS) shares are trading with a volume of 0.
In the last year, Pieris Pharmaceuticals(PIRS) shares hit a 52-week high of $18.68 and a 52-week low of $6.20.
In the last year, Pieris Pharmaceuticals(PIRS) shares hit a 52-week high of $18.68 and a 52-week low of $6.20.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.